Avisi Technologies

Avisi Technologies is a medical device company founded in 2017 through the University of Pennsylvania Y-Prize program. The company focuses on developing innovative nanotechnology-based solutions to combat vision loss and prevent blindness, particularly from glaucoma. Its mission is to create accessible healthcare solutions that restore health and promote vitality worldwide. The flagship product, VisiPlate®, is an investigational aqueous shunt designed to treat open-angle glaucoma, the leading cause of irreversible blindness. This ultrathin ocular implant lowers intraocular pressure by facilitating controlled drainage of excess aqueous fluid through a network of microchannels. Made from alumina and Parylene-C materials, VisiPlate® aims to minimize foreign body response and reduce scarring risk, enhancing patient comfort and treatment outcomes. Avisi Technologies utilizes advanced Micro-Electro-Mechanical Systems (MEMS) manufacturing and micro-fabrication techniques to produce its medical devices. With headquarters and R&D facilities in Redwood City, California, and a presence in Philadelphia, the company has received support from various prestigious organizations, including the National Science Foundation and Johnson & Johnson’s JLABS incubator.

• Employees 20
• Founded 2017
• Total Funding $6877168